New York State Health Dept. Warns Not Enough Paxlovid or Molnupiravir Antibody Treatment

This image provided by Pfizer in October 2021 shows the company's COVID-19 Paxlovid pills. Pfizer via AP

The New York State Health Department has warned that it does not have enough Paxlovid or Molnupiravir antibody treatment.

In a notification (pdf) issued on Dec. 27, the department warned there is currently a shortage of Paxlovid, a Pfizer oral COVID-19 antiviral pill, which has been authorized for emergency use by the U.S. Food and Drug Administration.